The Indian biotech and life sciences industry recorded the fastest pace of growth in the last five years in 2010-11 to touch revenues of $4 billion (Rs.18,399.34 crore), according to a survey.
Of this, the biotech industry contributed Rs.17,249.34 crore, while the life science education market made up the remaining Rs.1,150 crore, according to the 9th annual BioSpectrum-Association of Biotechnology Led Enterprises (ABLE) survey.
The biotech industry, without the life sciences education component, recorded a revenue growth of 21.5 per cent vis-a-vis 2009-10 revenues of Rs.14,199 crore.
The top 10 South-based companies, led by Biocon, accounted for $1 billion (Rs.4,816 crore) in revenues.
The contribution of the BioPharma, BioServices, BioAgri, Bioindustrials and Bioinformatics verticals was Rs.10,645 crore, Rs.3,245.97 crore, Rs.2,480 crore, Rs.626 crore and Rs.252 crore, respectively. The BioPharma vertical contributed almost two-fifths of industry revenues, followed by BioServices with 18.82 per cent and BioAgri with a 14.38 per cent contribution. Bioindustrials and BioInformatics made up the rest of the industry revenue.
Growth of biologics in the domestic market gave an 8 per cent boost to the BioPharma segment which clocked about 21 per cent growth in 2010-11.
Biocon retained its top slot of number one company in the overall revenue ranking, growing at a healthy 26 per cent. Of the top 20 companies, Shantha Biotech and Jubilant Life Sciences faced a drop in revenue while Ankur Seeds posted a spectacular growth in revenues.